REDOX MEDECINE Banner

News

ROS Production in Phagocytes: Why, When and Where?

Nusse

Pr Oliver Nüsse, from University Paris-Sud, Orsay, France will present a strategic topic about ROS production in phagocytes during next ISANH Congress.

Phagocytes produce ROS to kill pathogens. How much radicals and which species are required for efficient killing is still under debate. How does the phagocyte “know” when to stop ROS production? What are the consequences of ROS escaping from the phagosome? To answer these questions, more accurate methods to detect ROS in time and space will be required. Future detection methods need to deal with the diversity of biologically relevant ROS, a wide range of concentration and with localized, short term production.

Among the last publications of Pr Nüsse:

ROS Production in Phagocytes: Why, When and Where?

Abstract

In the phagocytosis field, ROS production by the phagocyte NOX has been associated with pathogen killing for the last 50 years. Since the discovery of nonphagocyte NOX, numerous other roles for ROS production have been identified. Oxidative stress and ROS-mediated signaling have received much attention in recent years. Much lower concentrations of ROS may be required for signaling compared with microbial killing. Based on the discoveries in nonphagocytic cells, it became logical to look for ROS functions distinct from pathogen killing, even in phagocytes. ROS are now linked to various forms of cell death, to chemotaxis, and to numerous modifications of cellular processes, including the NOX itself. ROS functions are clearly concentration-dependent over a wide range of concentrations. How much is required for which function? Which species are required for how much time? Is ROS signaling only a side effect of bactericidal ROS production? One major obstacle to answer these questions is the difficulty of reliable quantitative ROS detection. Signal transduction often takes place on a subcellular scale over periods of seconds or minutes, so the detection methods need to provide appropriate time and space resolution. We present examples of local ROS production, decreased degradation, signaling events, and potentially ROS-sensitive functions. We attempt to illustrate the current limitations for quantitative spatiotemporal ROS detection and point out directions for ongoing development. Probes for localized ROS detection and for combined detection of ROS, together with protein localization or other cellular parameters, are constantly improved.

More information: www.isanh.fr

 

Endothelial Dysfunctions on Intensive Care Units: Targeting Oxidative Stress & Interleukine-10 Modulation

vaisseausanguinDr Laurent Dupic, from Paris Hopitel Necker Hospital will give a translational talk  focusing on oxidative mechanism and opening on therapeutic perspective.

More information: www.isanh.fr

Oxidative Stress & Kidney Diseases: From Mechanistic of Oxidative Stress to Therapeutic Approaches

attafDr David Attaf, Paris, France, will highlight the impact of oxidative stress and inflammation on kidney diseases.

The mechanistic of oxidative stress on cellular signaling pathways and gene expression will be underline in term of therapeutics.

Clinical studies will be presented during ISANH Congress.

More information www.isanh.fr

 

How New Concepts in Redox Biology Changes Strategies for the Development of Antioxidants, by Pr Victor Darley-Usmar

VictorDarleyUsmarOn behalf of Scientific Committee of 12th ISANH Antioxidants World Congress 2013, we are pleased to welcoming Pr Victor Darley-Usmar. Pr Darley-Usmar will give a talk on How New Concepts in Redox Biology Changes Strategies for the Development of Antioxidants.

The impact of this talk that it will argue that since redox signaling is controlled by cellular domains targeting plasma antioxidant status is not a useful strategy.

Read more...

ROS as a strategic pharmacological target: The good VS bad side

Rama2Dr Ramaroson Andriantsitohaina, from University of Angers, France will participate to the strategic discussion about the Red Line between Pathologic ROS vs Physiologic ROS:



What kind of strategy we need urgently to determine the basal level of ROS in healthy human which can be used to identify pathologic ROS in unhealthey subject and ultimately guide antioxidants treatment?

 

For more information: www.isanh.fr

 



Scientific News

  • 1
  • 2
Prev Next


read all news